Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy

P. Melacini, A. Vianello, C. Villanova, M. Fanin, M. Miorin, C. Angelini, S. Dalla Volta

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

This study aimed to describe myocardial involvement, respiratory impairment and pulmonary blood flow abnormalities in advanced-stage Duchenne muscular dystrophy (DMD). Twenty-one wheelchair-bound patients, aged from 10 to 24 yr, underwent electrocardiographic and echocardiographic examination, conventional spirometry, diurnal arterial blood gas analysis, and nocturnal polysomnography (SaO2 monitoring). Diagnosis was confirmed by neurological examination, dystrophin analysis at protein and DNA level. Patients were classified into two groups: group A normoxemic (14 cases) and group B with nocturnal hypoxemia (seven cases). Group A was further split into two subgroups, one without, and one with, left ventricular dilation (A1 nine patients, end diastolic volume (EDV) = 51 ml m-2, ejection fraction (EF) = 56 per cent; A2 = five patients, EDV = 112 ml m2, EF = 32 per cent; P <0.05). Left ventricular regional wall motion abnormalities were found in 55, 40, and 43 per cent of groups A1, A2, and B patients respectively. Analysis of pulsed Doppler pulmonary data highlighted a significant reduction in corrected time to peak velocity in group B patients, when compared with control, A1, and A2 groups respectively. In group A, we observed a direct correlation between ejection fraction and corrected time-to-peak velocity. Two patterns of cardiac involvement may be recognized in advanced-stage DMD: left ventricular wall motion abnormalities and dilated cardiomyopathy. Doppler data which could suggest pulmonary hypertension may be observed in patients with dilated cardiomyopathy, and in patients with nocturnal hypoxemia. Therefore, in the management of advanced-stage DMD, a careful diagnosis of the heart-lung relationship should be performed, and both conventional treatment of heart failure and ventilatory therapy are necessary to improve the quality of life and survival in these patients.

Original languageEnglish
Pages (from-to)367-376
Number of pages10
JournalNeuromuscular Disorders
Volume6
Issue number5
DOIs
Publication statusPublished - Oct 1996

Fingerprint

Duchenne Muscular Dystrophy
varespladib methyl
Dilated Cardiomyopathy
Lung
Dystrophin
Blood Gas Analysis
Wheelchairs
Polysomnography
Spirometry
Neurologic Examination
Treatment Failure
Pulmonary Hypertension
Dilatation
Heart Failure
Quality of Life
Survival
DNA

Keywords

  • Advanced-stage Duchenne muscular dystrophy
  • Heart
  • Sleep hypoxemia

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology

Cite this

Melacini, P., Vianello, A., Villanova, C., Fanin, M., Miorin, M., Angelini, C., & Dalla Volta, S. (1996). Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy. Neuromuscular Disorders, 6(5), 367-376. https://doi.org/10.1016/0960-8966(96)00357-4

Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy. / Melacini, P.; Vianello, A.; Villanova, C.; Fanin, M.; Miorin, M.; Angelini, C.; Dalla Volta, S.

In: Neuromuscular Disorders, Vol. 6, No. 5, 10.1996, p. 367-376.

Research output: Contribution to journalArticle

Melacini, P, Vianello, A, Villanova, C, Fanin, M, Miorin, M, Angelini, C & Dalla Volta, S 1996, 'Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy', Neuromuscular Disorders, vol. 6, no. 5, pp. 367-376. https://doi.org/10.1016/0960-8966(96)00357-4
Melacini P, Vianello A, Villanova C, Fanin M, Miorin M, Angelini C et al. Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy. Neuromuscular Disorders. 1996 Oct;6(5):367-376. https://doi.org/10.1016/0960-8966(96)00357-4
Melacini, P. ; Vianello, A. ; Villanova, C. ; Fanin, M. ; Miorin, M. ; Angelini, C. ; Dalla Volta, S. / Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy. In: Neuromuscular Disorders. 1996 ; Vol. 6, No. 5. pp. 367-376.
@article{78c2d13e67b44f36940253033702c4fc,
title = "Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy",
abstract = "This study aimed to describe myocardial involvement, respiratory impairment and pulmonary blood flow abnormalities in advanced-stage Duchenne muscular dystrophy (DMD). Twenty-one wheelchair-bound patients, aged from 10 to 24 yr, underwent electrocardiographic and echocardiographic examination, conventional spirometry, diurnal arterial blood gas analysis, and nocturnal polysomnography (SaO2 monitoring). Diagnosis was confirmed by neurological examination, dystrophin analysis at protein and DNA level. Patients were classified into two groups: group A normoxemic (14 cases) and group B with nocturnal hypoxemia (seven cases). Group A was further split into two subgroups, one without, and one with, left ventricular dilation (A1 nine patients, end diastolic volume (EDV) = 51 ml m-2, ejection fraction (EF) = 56 per cent; A2 = five patients, EDV = 112 ml m2, EF = 32 per cent; P <0.05). Left ventricular regional wall motion abnormalities were found in 55, 40, and 43 per cent of groups A1, A2, and B patients respectively. Analysis of pulsed Doppler pulmonary data highlighted a significant reduction in corrected time to peak velocity in group B patients, when compared with control, A1, and A2 groups respectively. In group A, we observed a direct correlation between ejection fraction and corrected time-to-peak velocity. Two patterns of cardiac involvement may be recognized in advanced-stage DMD: left ventricular wall motion abnormalities and dilated cardiomyopathy. Doppler data which could suggest pulmonary hypertension may be observed in patients with dilated cardiomyopathy, and in patients with nocturnal hypoxemia. Therefore, in the management of advanced-stage DMD, a careful diagnosis of the heart-lung relationship should be performed, and both conventional treatment of heart failure and ventilatory therapy are necessary to improve the quality of life and survival in these patients.",
keywords = "Advanced-stage Duchenne muscular dystrophy, Heart, Sleep hypoxemia",
author = "P. Melacini and A. Vianello and C. Villanova and M. Fanin and M. Miorin and C. Angelini and {Dalla Volta}, S.",
year = "1996",
month = "10",
doi = "10.1016/0960-8966(96)00357-4",
language = "English",
volume = "6",
pages = "367--376",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Ltd",
number = "5",

}

TY - JOUR

T1 - Cardiac and respiratory involvement in advanced stage duchenne muscular dystrophy

AU - Melacini, P.

AU - Vianello, A.

AU - Villanova, C.

AU - Fanin, M.

AU - Miorin, M.

AU - Angelini, C.

AU - Dalla Volta, S.

PY - 1996/10

Y1 - 1996/10

N2 - This study aimed to describe myocardial involvement, respiratory impairment and pulmonary blood flow abnormalities in advanced-stage Duchenne muscular dystrophy (DMD). Twenty-one wheelchair-bound patients, aged from 10 to 24 yr, underwent electrocardiographic and echocardiographic examination, conventional spirometry, diurnal arterial blood gas analysis, and nocturnal polysomnography (SaO2 monitoring). Diagnosis was confirmed by neurological examination, dystrophin analysis at protein and DNA level. Patients were classified into two groups: group A normoxemic (14 cases) and group B with nocturnal hypoxemia (seven cases). Group A was further split into two subgroups, one without, and one with, left ventricular dilation (A1 nine patients, end diastolic volume (EDV) = 51 ml m-2, ejection fraction (EF) = 56 per cent; A2 = five patients, EDV = 112 ml m2, EF = 32 per cent; P <0.05). Left ventricular regional wall motion abnormalities were found in 55, 40, and 43 per cent of groups A1, A2, and B patients respectively. Analysis of pulsed Doppler pulmonary data highlighted a significant reduction in corrected time to peak velocity in group B patients, when compared with control, A1, and A2 groups respectively. In group A, we observed a direct correlation between ejection fraction and corrected time-to-peak velocity. Two patterns of cardiac involvement may be recognized in advanced-stage DMD: left ventricular wall motion abnormalities and dilated cardiomyopathy. Doppler data which could suggest pulmonary hypertension may be observed in patients with dilated cardiomyopathy, and in patients with nocturnal hypoxemia. Therefore, in the management of advanced-stage DMD, a careful diagnosis of the heart-lung relationship should be performed, and both conventional treatment of heart failure and ventilatory therapy are necessary to improve the quality of life and survival in these patients.

AB - This study aimed to describe myocardial involvement, respiratory impairment and pulmonary blood flow abnormalities in advanced-stage Duchenne muscular dystrophy (DMD). Twenty-one wheelchair-bound patients, aged from 10 to 24 yr, underwent electrocardiographic and echocardiographic examination, conventional spirometry, diurnal arterial blood gas analysis, and nocturnal polysomnography (SaO2 monitoring). Diagnosis was confirmed by neurological examination, dystrophin analysis at protein and DNA level. Patients were classified into two groups: group A normoxemic (14 cases) and group B with nocturnal hypoxemia (seven cases). Group A was further split into two subgroups, one without, and one with, left ventricular dilation (A1 nine patients, end diastolic volume (EDV) = 51 ml m-2, ejection fraction (EF) = 56 per cent; A2 = five patients, EDV = 112 ml m2, EF = 32 per cent; P <0.05). Left ventricular regional wall motion abnormalities were found in 55, 40, and 43 per cent of groups A1, A2, and B patients respectively. Analysis of pulsed Doppler pulmonary data highlighted a significant reduction in corrected time to peak velocity in group B patients, when compared with control, A1, and A2 groups respectively. In group A, we observed a direct correlation between ejection fraction and corrected time-to-peak velocity. Two patterns of cardiac involvement may be recognized in advanced-stage DMD: left ventricular wall motion abnormalities and dilated cardiomyopathy. Doppler data which could suggest pulmonary hypertension may be observed in patients with dilated cardiomyopathy, and in patients with nocturnal hypoxemia. Therefore, in the management of advanced-stage DMD, a careful diagnosis of the heart-lung relationship should be performed, and both conventional treatment of heart failure and ventilatory therapy are necessary to improve the quality of life and survival in these patients.

KW - Advanced-stage Duchenne muscular dystrophy

KW - Heart

KW - Sleep hypoxemia

UR - http://www.scopus.com/inward/record.url?scp=0030273734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030273734&partnerID=8YFLogxK

U2 - 10.1016/0960-8966(96)00357-4

DO - 10.1016/0960-8966(96)00357-4

M3 - Article

C2 - 8938701

AN - SCOPUS:0030273734

VL - 6

SP - 367

EP - 376

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 5

ER -